Current Diabetes Reports

, Volume 2, Issue 1, pp 60–66 | Cite as

Erectile dysfunction and diabetes

  • Neelima V. Chu
  • Steven V. Edelman


Erectile dysfunction (ED) has been the most neglected complication of diabetes. It is a common abnormality that affects more than 20 million American men. The prevalence of ED in the general population between the ages of 40 to 70 years is 52%. In men with diabetes, it ranges from 35% to 75%, and occurs at an earlier age. There have been several advances in the understanding of the physiologic and biochemical mechanisms controlling penile erections. Improved techniques in diagnoses and treatment of impotence have given the male with diabetes some hope in the management of this prevalent and emotionally disturbing complication.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Feldman HA, Goldstein I, Hatzichristou DG, et al.: Impotence and its medical and psychological correlates: results of the Massachusetts male aging study. J Urol 1994, 151:54–61.PubMedGoogle Scholar
  2. 2.
    Lewis RW: Epidemiology of erectile dysfunction. Urol Clin North Am 2001, 28:209–215. Summarizes the recent studies showing the incidence and prevalence of ED.PubMedCrossRefGoogle Scholar
  3. 3.
    Hakim LS, Goldstein I: Diabetic sexual dysfunction. Endocrinol Clin North Am 1996, 25:379–400.CrossRefGoogle Scholar
  4. 4.
    NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence [no authors listed]. JAMA 1993, 270:83–90.Google Scholar
  5. 5.
    Lue TF: Erectile dysfunction. N Engl J Med 2000, 342:1802–1813.PubMedCrossRefGoogle Scholar
  6. 6.
    Levine LA: Diagnosis and treatment of erectile dysfunction. Am J Med 2000, 109: 3S-12S.PubMedCrossRefGoogle Scholar
  7. 7.
    Spark RF: Overview of male sexual dysfunction. In Up-To-Date, vol 7 [educational disc]. Edited by Rose BD. Wellesley, MA: 2000:1–5; also available at: // Scholar
  8. 8.
    Nehra A, Moreland RB: Neurologic erectile dysfunction. Urol Clin North Am 2001, 28:289–308.PubMedCrossRefGoogle Scholar
  9. 9.
    Rampin O, Bernabe J, Giuliano F: Spinal control of penile erection. Wor l d J Ur ol 1997, 15:2–13.CrossRefGoogle Scholar
  10. 10.
    Hoffman AR, Crowley WF: Induction of puberty in men by long-term pulsatile administration of low dose gonadotropin-releasing hormone. N Engl J Med 1982, 307:1237–1241.PubMedCrossRefGoogle Scholar
  11. 11.
    Rosen RC: Psychogenic erectile dysfunction. Urol Clin North Am 2001, 28:269–278.PubMedCrossRefGoogle Scholar
  12. 12.
    Nisen HO, Larsen A, Lindstrom BL, et al.: Cardiovascular reflex in the neurological evaluation of impotence. Br J Urol 1993, 71: 199–203.PubMedCrossRefGoogle Scholar
  13. 13.
    Buvat J, Quittelier E, Lemaire A, et al.: Electromyography of the human penis, including single potential analysis during flaccidity and erection induced by vasoactive agents. Int J Impot Res 1990, 2(suppl):85–86.Google Scholar
  14. 14.
    Lincoln J, Crome R, Blacklay PF, et al.: Changes in the VIPergic, cholinergic and adrenergic innervation of human penile tissue in diabetic and non diabetic impotent males. J Urol 1987, 137:1053–1059.PubMedGoogle Scholar
  15. 15.
    Saenz de Tejada I, Goldstein I, Azadzoi K, et al.: Impaired neurogenic and endothelium mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989, 320:1025–1030.PubMedCrossRefGoogle Scholar
  16. 16.
    Virag R, Bouilly P, Frydaman D: Is impotence an arterial disorder? A study of arterial risk factors in 400 impotent men. Lancet 1985, 1:181–184.PubMedCrossRefGoogle Scholar
  17. 17.
    Morales A, Heaton JPW: Hormonal erectile dysfunction. Urol Clin North Am 2001, 28:279–287. Discusses in detail the hormonal evaluation and management of ED, with specific recommendations regarding androgen therapy in men.PubMedCrossRefGoogle Scholar
  18. 18.
    AACE clinical practice guidelines for the evaluation and treatment of male sexual dysfunction [no authors listed]. Endocr Pract 1998, 4:219–234.Google Scholar
  19. 19.
    Paty BW, Hirsch I: Erectile dysfunction in diabetes. Practical Diabetol 2000, June:16–23.Google Scholar
  20. 20.
    Greiner KA, Weigel JW: Erectile dysfunction. Am Fam Physician 1996, 54:1675–1682.PubMedGoogle Scholar
  21. 21.
    Padma-Nathan H, Giuliano F: Oral drug therapy for erectile dysfunction. Urol Clin North Am 2001, 28:321–334.PubMedCrossRefGoogle Scholar
  22. 22.
    Rendell MS, Rajfer J, Wicker PA, et al.: Sildenafil, a novel oral therapy for penile erectile dysfunction in patients with diabetes. JAMA 1999, 281:421–426.PubMedCrossRefGoogle Scholar
  23. 23.
    Viagra [package insert]. New York: Pfizer Inc.; 1999.Google Scholar
  24. 24.
    Cheitlin MD, Hutter AM, Brindis RG, et al.: Use of sildenafil (Viagra) in patients with cardiovascular disease. Circulation 1999, 99:168–177. An expert consensus statement developed by the American College of Cardiology and American Heart Association regarding the use of sildenafil for ED.PubMedGoogle Scholar
  25. 25.
    Kloner RA: Sex and patient with cardiovascular risk factors: focus on sildenafil 2000, 109: 13S–21S.Google Scholar
  26. 26.
    Leungwattanakij S, Flynn V, Hellstrom WJG: Intracavernosal injection and intraurethral therapy for erectile dysfunction. Urol Clin North Am 2001, 28:343–354.PubMedCrossRefGoogle Scholar
  27. 27.
    Lakin MM, Montague DR, Medendorp SV, et al.: Intracaverous injection therapy: analysis of results and complications. J Urol 1990, 143:1138–1141.PubMedGoogle Scholar
  28. 28.
    Labasky RC, Spivack AP: Transurethral alprostadil for treatment of erectile dysfunction: two-year safety update [abstract]. J Urol 1998, 159:907A.Google Scholar
  29. 29.
    Trapp JD, Edelman SV: Male impotence is a couple’s problem. In Taking Control of Your Diabetes. Caddo, LA: Professional Communications; 2000:81.Google Scholar
  30. 30.
    Levine LA, Dimitiou RJ: Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am 2001, 28:355–361. Examines the development, mechanism of action, efficacy, and patient satisfaction with regard to all vacuum constriction and external erection devices.CrossRefGoogle Scholar
  31. 31.
    Montague DK, Angermeier KW: Penile prosthesis implantation. Urol Clin North Am 2001, 28:355–361.PubMedCrossRefGoogle Scholar
  32. 32.
    McLaren RH, Barrett DM: Patient and partner satisfaction with AMS 700 penile prosthesis. J Urol 1992, 147:62–65.PubMedGoogle Scholar
  33. 33.
    Rao S, Donatucci CF: Vasculogenic impotence: arterial and venous surgery. Urol Clin North Am 2001, 28:309–391.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2002

Authors and Affiliations

  • Neelima V. Chu
    • 1
  • Steven V. Edelman
  1. 1.VA Healthcare San DiegoSan DiegoUSA

Personalised recommendations